Kirsty has been the Head of Regulatory Strategy at Weatherden, a global integrated consultancy, since 2022. Kirsty joined Weatherden from the MHRA where she was an expert medical assessor in the Clinical Trials Unit for nearly 14 years, with particular expertise in advanced therapies, first-in-human trials and novel trial designs. During the Covid-19 pandemic, Kirsty worked on the UK Government Vaccine Taskforce, providing regulatory support to DHSC and NIHR. She currently chairs the Clinical Trial Science and Regulations Expert Group of FPM, is an expert on the Drug Development Advisory Board of CRO Simbec-Orion and is a senior lecturer for Kings College London.